Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy.
Miller BW, Morton JP, Pinese M, Saturno G, Jamieson NB, McGhee E, Timpson P, Leach J, McGarry L, Shanks E, Bailey P, Chang D, Oien K, Karim S, Au A, Steele C, Carter CR, McKay C, Anderson K, Evans TR, Marais R, Springer C, Biankin A, Erler JT, Sansom OJ.
Miller BW, et al. Among authors: carter cr.
EMBO Mol Med. 2015 Aug;7(8):1063-76. doi: 10.15252/emmm.201404827.
EMBO Mol Med. 2015.
PMID: 26077591
Free PMC article.